- Nachrichtendetail
-
31.05.2024 14:07:20 - dpa-AFX: *NOVARTIS SCEMBLIX PHASE III DATA REVEALS SUPERIOR EFFICACY & SAFETY VS. STANDARD TKIS IN CML
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
NOVARTIS NAM. SF 0,49 | 904278 | Hamburg | 0,000 | 18.06.24 14:42:42 | ±0,000 | ±0,00% | 0,000 | 0,000 | 0,000 | 80,190 |
